Zentalis Pharmaceuticals, Inc.

Q2 2023 13F Holders

Symbol
ZNTL
CUSIP
98943L107
Type
Equity
Class
COM
Num filings
141
Total reported value, excl. options
$2.32 B
Manager Report Date Value ($000) Shares Option Type